Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Protein Precipitation Method in Plasma – V 2.0

Posted on By

BA-BE Studies: SOP for Protein Precipitation Method in Plasma – V 2.0

Standard Operating Procedure for Protein Precipitation Method in Plasma for BA/BE Bioanalytical Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/159/2025
Supersedes SOP/BA-BE/159/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a standard procedure for the extraction of analytes from plasma samples using the protein precipitation method for bioanalytical sample preparation in BA/BE studies.

2. Scope

This SOP is applicable to all bioanalytical personnel performing protein precipitation for the quantification of drug compounds in human plasma for BA/BE studies.

3. Responsibilities

  • Analyst: Conducts all steps of the protein precipitation process
and documents observations.
  • QA Reviewer: Reviews procedure adherence, batch records, and ensures compliance with validated method.
  • Lab Supervisor: Ensures availability of required solvents and functioning of instruments like centrifuges and vortex mixers.
  • 4. Accountability

    The Head of the Bioanalytical Department is accountable for overall compliance, data integrity, and validated performance of the protein precipitation method.

    5. Procedure

    5.1 Pre-Extraction Preparation

    1. Thaw plasma samples according to SOP/BA-BE/155/2025.
    2. Ensure labeling of tubes with sample ID, study code, and date.
    3. Prepare internal standard (IS) and precipitation solvents (methanol or acetonitrile) in advance.
    4. Document lot numbers and preparation time in Annexure-1: Solvent Preparation Log.

    5.2 Protein Precipitation Process

    1. Add a defined volume (e.g., 50 µL) of IS to each 200 µL plasma sample.
    2. Vortex the mixture for 10 seconds to ensure uniform distribution.
    3. Add precipitation solvent (usually 600–800 µL) based on validated ratio (typically 3–4x plasma volume).
    4. Vortex the sample vigorously for 1 minute.
    5. Incubate the tubes at room temperature for 5 minutes for complete precipitation.
    6. Centrifuge at 10,000 rpm for 10 minutes at 4°C to pellet proteins.
    7. Carefully collect the supernatant into a clean autosampler vial or labeled Eppendorf tube.

    5.3 Post-Precipitation Handling

    1. If necessary, evaporate the supernatant under nitrogen and reconstitute with 200 µL of mobile phase.
    2. Filter through 0.2 µm filter (optional, based on method) before LC-MS/MS injection.
    3. Record processing time, centrifuge RPM, and temperature in Annexure-2: Protein Precipitation Log.

    5.4 Critical Considerations

    1. Avoid delay between vortexing and centrifugation to prevent re-solubilization of proteins.
    2. Use freshly prepared IS and solvent each day.
    3. Ensure no pellet disturbance while transferring supernatant.

    5.5 Deviation and Troubleshooting

    1. In case of incomplete precipitation or turbid supernatant, repeat centrifugation and report deviation in Annexure-3: Deviation Report Form.
    2. Use backup aliquots only with QA approval.

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • IS: Internal Standard
    • PPE: Personal Protective Equipment
    • LC-MS/MS: Liquid Chromatography–Mass Spectrometry

    7. Documents

    1. Solvent Preparation Log – Annexure-1
    2. Protein Precipitation Log – Annexure-2
    3. Deviation Report Form – Annexure-3

    8. References

    • ICH M10 – Bioanalytical Method Validation
    • FDA/EMA Bioanalytical Method Guidelines
    • Validated Study Protocols

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Solvent Preparation Log

    Solvent Lot No. Purity Prepared On Prepared By
    Acetonitrile ACN-234 HPLC Grade 17/04/2025 Vinay Pawar

    Annexure-2: Protein Precipitation Log

    Date Sample ID IS Volume Solvent Volume Centrifuge RPM Analyst
    17/04/2025 PLM-3012 50 µL 600 µL 10,000 Rajesh Kumar

    Annexure-3: Deviation Report Form

    Date Sample ID Description of Deviation Corrective Action Approved By
    17/04/2025 PLM-3012 Turbid Supernatant Re-centrifuged Sunita Reddy

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial Release New SOP QA Head
    17/04/2025 2.0 Improved clarity in volume ratios and added deviation tracking Annual Review QA Head
    See also  BA-BE Studies: SOP for Handling Deviations in PK Sampling Time - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: Creams: SOP for Performing Inline pH Adjustments during Production – V 2.0
    Next Post: Gel Manufacturing: SOP for Operation of pH Meters During Gel Production – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version